The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A pilot trial evaluating the rapid sequencing of approved therapies in patients (pts) with advanced clear cell renal cell carcinoma (ccRCC).
 
Qian Qin
Honoraria - Curio Science; OncLive/MJH Life Sciences
Consulting or Advisory Role - Exelixis
 
Nicole J. Zubizarreta
No Relationships to Disclose
 
Matt D. Galsky
Stock and Other Ownership Interests - Rappta Therapeutics
Consulting or Advisory Role - Aileron Therapeutics; Astellas Pharma; AstraZeneca; Basilea; BioMotiv; Bristol-Myers Squibb; Dendreon; Dracen; Dragonfly Therapeutics; EMD Serono; Genentech; Gilead Sciences; GlaxoSmithKline; Incyte; Infinity Pharmaceuticals; Inovio Pharmaceuticals; Janssen; Lilly; Merck; Novartis; NuMab; Pfizer; Seagen; Silverback Therapeutics; Urogen pharma
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - METHODS AND COMPOSITIONS FOR TREATING CANCER AND RELATED METHODS. MOUNT SINAI SCHOOL OF MEDICINE July 2012 Application number: 20120322792
 
Bobby Chi-Hung Liaw
Consulting or Advisory Role - Bristol Myers Squibb; Bristol Myers Squibb; Daiichi Sankyo; Eisai; EMD Serono; Epizyme; Exelixis; Janssen Biotech; Myovant Sciences
Research Funding - Bayer; Sanofi
 
Vaibhav G. Patel
Employment - Arvinas
Stock and Other Ownership Interests - Arvinas; Bellicum Pharmaceuticals; crispr therapeutics; Editas Medicine; Finch Therapeutics
Consulting or Advisory Role - Sanofi; Seagen
 
John P. Sfakianos
Consulting or Advisory Role - EMD Serono
Speakers' Bureau - Astellas Medivation
 
Reza Mehrazin
No Relationships to Disclose
 
Michael Palese
No Relationships to Disclose
 
Ketan Badani
No Relationships to Disclose
 
Nikhil Waingankar
No Relationships to Disclose
 
Rachel Brody
No Relationships to Disclose
 
Nina Bhardwaj
Leadership - American Association for Cancer Research
Stock and Other Ownership Interests - Apricity Health; Genotwin; PrimeVax
Honoraria - Pfizer; U.S. Food and Drug Administration
Consulting or Advisory Role - American Association for Cancer Research; Apricity Health; BioNTech SE; Boehringer Ingelheim; BreakBio Corp.; Carisma Therapeutics; CureVac; Genotwin; Gilead Sciences; Novartis; Parker Institute for Cancer Immunotherapy; PrimeVax; Roche/Genentech; rome; Rubius Therapeutics; Tempest Therapeutics
Research Funding - Celldex (Inst); Genentech (Inst); Novocure (Inst); Oncovir (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - Parker Institute for Cancer Immunotherapy
 
Amish Doshi
No Relationships to Disclose
 
William L Simpson
No Relationships to Disclose
 
David F Yankelevitz
Stock and Other Ownership Interests - Accumetra
Consulting or Advisory Role - GRAIL
Patents, Royalties, Other Intellectual Property - I am a named inventor on a number of patents and patent applications relating to the evaluation of diseases of the chest including measurement of nodules. Some of these, which are owned by Cornell Research Foundation (CRF), are non-exclusively licensed to
 
Amir Horowitz
No Relationships to Disclose
 
Kai Tsao
Consulting or Advisory Role - Bristol-Myers Squibb/Sanofi; Eisai; Exelixis
Research Funding - Exelixis; Exelixis